Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4288322 | 0.95 | CA1 (0.38) | CA1CA2CA4KMT2A | |
| SCHEMBL11572154 | 0.93 | KMT2A (0.40) | CA1CA2CA4KMT2A | |
| SCHEMBL8419229 | 0.93 | KMT2A (0.40) | CA1CA2CA4KMT2A | |
| SCHEMBL22388204 | 0.74 | TLR4 (0.33) | CA1CA2CA4KMT2A | |
| SCHEMBL22388203 | 0.74 | TLR4 (0.33) | CA1CA2CA4KMT2A | |
| SCHEMBL20464012 | 0.71 | — | — | |
| SCHEMBL4290685 | 0.71 | — | — | |
| SCHEMBL19141681 | 0.70 | CA1 (0.35) | CA1CA2CA4KMT2A | |
| SCHEMBL4290970 | 0.66 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL21812504 | 0.66 | POLB (0.39) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3856709-B1 | SYNTHESIS OF CYCLOPENTENONES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20210221761-A1 | SYNTHESIS OF SUBSTITUTED CYCLOPENTADIENE COMPOUNDS AND METALLOCENES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-07-22 | — | — | US | disclosed |
| US-20210206709-A1 | SYNTHESIS OF CYCLOPENTENONES | DOW GLOBAL TECHNOLOGIES LLC | 2021-07-08 | — | — | US | disclosed |
| WO-2020068420-A1 | SYNTHESIS OF SUBSTITUTED CYCLOPENTADIENE COMPOUNDS AND METALLOCENES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210221761-A1 | SYNTHESIS OF SUBSTITUTED CYCLOPENTADIENE COMPOUNDS AND METALLOCENES | MSMO1, NOTUM, GGPS1 | CA1 661/4885CA2 1357/4885CA4 562/4885 |
| US-20210206709-A1 | SYNTHESIS OF CYCLOPENTENONES | FDPS, COASY, DHPS | CA1 2944/4885CA2 2741/4885CA4 1811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.